Eser, A. Et Al. 2018. Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia. BEZMIALEM SCIENCE , vol.6, no.3 , 233-235.

Eser, A., Sezgin, A., Kara, O., & Uyar Bozkurt, S., (2018). Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia. BEZMIALEM SCIENCE , vol.6, no.3, 233-235.

Eser, Ali Et Al. "Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia," BEZMIALEM SCIENCE , vol.6, no.3, 233-235, 2018

Eser, Ali Et Al. "Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia." BEZMIALEM SCIENCE , vol.6, no.3, pp.233-235, 2018

Eser, A. Et Al. (2018) . "Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia." BEZMIALEM SCIENCE , vol.6, no.3, pp.233-235.

@article{article, author={Ali Eser Et Al. }, title={Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia}, journal={BEZMIALEM SCIENCE}, year=2018, pages={233-235} }